Last reviewed · How we verify
NCT06863896: LHarSAL
Laparoscopic Hartmann's Reversal Procedure: In the Absence of Standardized Guidelines, we Started a Database of Patient Submitted Reversal Hartman With Standard Technique and Laparoscopic Technique, Prospectively for One Year and a Follow-up Period of 6 Months
trial testing Hartmann's reversal in Colostomy - Stoma in 201 participants. Not yet recruiting.
30 June 2026
Quick facts
| Lead sponsor | Azienda USL Toscana Centro |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 201 |
| Start date | 1 June 2025 |
| Primary completion | 30 June 2026 |
| Estimated completion | 31 December 2026 |
Drugs / interventions tested
- Hartmann's reversal
Conditions studied
- Colostomy - Stoma — all drugs for Colostomy - Stoma →
Sponsor
Azienda USL Toscana Centro
Who can join
18 and older, any sex, with Colostomy - Stoma. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several studies have shown laparoscopic technique's advantages, including more rapid post-operative recovery, less post-operative pain, earlier restoration of bowel function, more rapid return to normal diet, and reduced morbidity but it could still remain a complicated operation due to adhesions and difficulty in identifying the rectal stump. Nevertheless, nowadays laparoscopic technique has largely become part of clinical practice even for younger surgeons. Assumed this, and in the lack of prospective studies, we aimed to confirm the advantages of laparoscopic Hartmann reversal (LHR) by confirming the difference in peri-operative outcomes and postoperative complications. In clinical practice, the first question to be asked is whether there is a right timing for a patient to undergo Hartmann's reversal procedure and whether timing influences the incidence of complications (short-terms and long-terms outcomes). Another aim of the study is to investigate if the length of rectal stump influences the outcome of Hartmann's reversal surgery.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06863896
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Colostomy - Stoma
Currently open trials in the same condition.
- NCT06737887 — The Effect of Preoperative Stoma Simulation on Anxiety and Postoperative Adaptation · NA · recruiting
- NCT07464548 — Effects of Stoma Education on Patients · NA · recruiting
- NCT07138326 — Impact on the Absorption of Drugs in Ostomy Patients · recruiting
- NCT06739174 — Assessment of Colostomy Bags with an Active Chamber Filter System and Incidence of Filter-Related Complication · NA · recruiting
Other Azienda USL Toscana Centro trials
Trials by the same sponsor.
- NCT05250596 — COLchicine On-admission to Reduce Inflammation in Acute Coronary Syndrome (COLOR-ACS) · Phase 2 · completed
- NCT04141410 — Global Longitudinal Strain Assessment in Cardiogenic Shock During Sepsis · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06863896 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Azienda USL Toscana Centro
- Last refreshed: 7 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06863896.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing